Design (Testphase)
Momentum & Trend
Qullamaggie: Top Gainers 6M
36
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 36 hits from US
Kullamägi's biggest-gainers screen over 6 months — exactly per his original filters: 6-month Absolute Strength rating (AS) > 97, the strongest roughly 3% over the half-year; plus ADR ≥ 3.5% and average dollar volume over the last 50 days > $1.5M. The long-term leaders — where the cleanest continuation bases form. AS = our RS rating (percentile 1–99).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(18)
- Absolute Strength (AS)
- The strength rating from Qullamaggie's original tool: a percentile from 1 to 99 for price gains over a period (1, 3, or 6 months). On our site it corresponds to the RS Rating over the same period.
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Long / Short
- Long = betting on rising prices (buying the stock). Short = betting on falling prices (selling borrowed shares to buy them back cheaper later). Our short scanners are warning or watch lists - not buy candidates.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VICR Vicor Corporation | 07/28 | +178 % | 78 8/25 | Stage 2 | A 78 | 5 of 9 | 10.3 $ | Electronic Components | Neutral | — | Technology | 207.40 $ | +206.7 % | +238.2 % | +366.6 % | −10.2 % | +86.2 % | 99 | 96 | 9.3 % | 9.4 % | 2.34 | 68.4 | 68.0 | 21.8 | 12.4 | 117.6 | — | 83.2 | 15.0 % | 56.6 % | 30.7 % | 20.5 % | 7.5 % | 0.01 | 93.7 % | +13.6 % | 8 | 0.0 % | 0.0 % | 26.2 | 63.3 % | 6.3 % | 3.3 (4) | |
| MXL MaxLinear Inc | 07/22 | +69 % | 72 7/25 | Stage 2 | B 64 | 4 of 9 | 6.0 $ | Semiconductors | Sells AI | — | Technology | 66.80 $ | +411.1 % | +518.4 % | +322.4 % | −11.1 % | +41.5 % | 99 | 8 | 10.9 % | 11.9 % | 3.93 | — | 38.5 | 10.5 | 11.9 | 1,813.6 | 0.39 | 12.3 | -12.2 % | 57.5 % | -18.2 % | -27.9 % | -4.9 % | 0.33 | 58.9 % | +29.7 % | 4 | 0.0 % | 0.0 % | 2.4 | 87.4 % | 6.0 % | 4.2 (11) | |
| SYRE Spyre Therapeutics Inc. | 08/04 | +290 % | 79 7/22 | Stage 2 | D 32 | 2 of 9 | 8.8 $ | Biotechnology | – | — | — | Healthcare | 98.30 $ | +196.2 % | +172.8 % | +479.4 % | −13.1 % | +7.6 % | 99 | 1 | 7.6 % | 6.7 % | 3.02 | — | 0.0 | 97.5 | 16.6 | — | — | -8.0 | 0.0 % | — | 0.0 % | -31.1 % | -22.7 % | — | 87.8 % | -100.0 % | 2 | 0.0 % | 0.0 % | 9.5 | 93.2 % | 15.4 % | 4.8 (11) |
| AEHR Aehr Test Systems | 07/14 | +52 % | 80 8/25 | Stage 2 | B 56 | 2 of 9 | 2.5 $ | Semiconductor Equipment & Materials | – | — | — | Technology | 80.00 $ | +407.1 % | +329.4 % | +373.3 % | −22.0 % | +43.8 % | 99 | 4 | 11.7 % | 12.5 % | 3.18 | — | 9.9 | 50.3 | 16.9 | — | 0.90 | 29.8 | -41.0 % | 35.3 % | -14.2 % | -8.7 % | -4.5 % | 0.07 | 88.4 % | -11.0 % | 4 | 0.0 % | 0.0 % | 13.6 | 73.3 % | 15.6 % | 4.0 (2) |
| ERAS Erasca Inc | 08/11 | +154 % | 88 8/22 | Stage 2 | D 25 | 2 of 9 | 5.8 $ | Biotechnology | Uses AI | — | Healthcare | 18.20 $ | +305.1 % | +433.2 % | +1,182.7 % | −38.4 % | +25.3 % | 99 | 42 | 8.6 % | 8.3 % | 0.67 | — | 0.0 | — | 14.5 | — | — | -1.6 | 0.0 % | — | 0.0 % | -69.9 % | -17.9 % | 0.12 | 85.3 % | — | 3 | 0.0 % | 0.0 % | 1.0 | 93.3 % | 9.8 % | 4.6 (8) | |
| AXTI AXT Inc | 07/30 | +758 % | 95 11/25 | Stage 2 | B 67 | 6 of 9 | 4.0 $ | Semiconductor Equipment & Materials | – | — | — | Technology | 60.40 $ | +376.5 % | +376.1 % | +2,805.3 % | −51.8 % | +51.7 % | 99 | 13 | 14.0 % | 14.6 % | 1.87 | — | 196.1 | 41.2 | 14.8 | — | 12.09 | 707.4 | — | 32.2 % | 3.2 % | -5.0 % | 0.3 % | 0.26 | — | -11.1 % | 4 | 0.0 % | 0.0 % | 7.6 | 58.1 % | 17.6 % | 4.8 (5) |
| OPTX Syntec Optics Holdings Inc. | — | -28 % | 82 8/25 | Stage 2 | D 31 | 4 of 9 | 0.3 $ | Electronic Components | – | — | — | Technology | 6.50 $ | +289.2 % | +326.6 % | +262.8 % | −34.3 % | — | 99 | 13 | 12.3 % | 15.1 % | -0.85 | — | 0.0 | 9.1 | — | — | — | 778.0 | — | 18.8 % | -11.0 % | -30.0 % | -4.6 % | — | — | -4.6 % | — | 0.0 % | 0.0 % | 5.1 | 3.5 % | 21.0 % | — |
| TTMI TTM Technologies Inc | 07/29 | +498 % | — | Stage 2 | B 69 | 6 of 9 | 0.0 $ | Electronic Components | – | — | — | Technology | 115.40 $ | +208.9 % | +157.3 % | +144.3 % | −5.9 % | +0.7 % | 98 | 50 | 7.5 % | 8.3 % | 2.10 | 96.6 | 5.6 | — | 10.1 | — | 0.36 | 39.9 | 8.6 % | 21.0 % | 6.3 % | 11.4 % | 4.9 % | 0.90 | 46.2 % | +19.0 % | 6 | 0.0 % | 0.0 % | 7.0 | 96.0 % | 6.0 % | 1.0 (4) |
| DOCN DigitalOcean Holdings Inc | 08/04 | +102 % | 92 10/25 | Stage 2 | B 72 | 4 of 9 | 13.0 $ | Software - Infrastructure | – | — | — | Technology | 117.50 $ | +226.6 % | +204.8 % | +321.8 % | −22.5 % | +50.5 % | 98 | 11 | 8.4 % | 8.1 % | 1.57 | 52.9 | 97.1 | 13.7 | 14.1 | 1,223.6 | 1.54 | 38.7 | 14.2 % | 58.5 % | 25.0 % | 70.0 % | 4.6 % | 1.68 | 34.5 % | +15.5 % | 9 | 0.0 % | 0.0 % | 5.1 | 94.1 % | 14.2 % | 3.6 (14) |
| HUT Hut 8 Corp. Common Stock | 08/06 | +241 % | 68 6/22 | Stage 2 | C 53 | 5 of 9 | 11.9 $ | Capital Markets | Sells AI | — | Financial Services | 107.60 $ | +162.3 % | +124.0 % | +407.0 % | −16.4 % | +47.6 % | 98 | 98 | 8.9 % | 9.3 % | 6.07 | — | 84.7 | — | 8.7 | — | — | 11.9 | -521.5 % | 59.7 % | -109.8 % | -27.4 % | -16.2 % | 0.36 | 52.9 % | -90.7 % | 1 | 0.0 % | 0.0 % | 3.4 | 80.5 % | 11.6 % | 4.6 (15) | |
| AAOI Applied Optoelectronics, Inc. | 08/06 | +1,099 % | 92 10/25 | Stage 2 | B 62 | 4 of 9 | 7.6 $ | Communication Equipment | Sells AI | — | — | Technology | 94.30 $ | +322.9 % | +266.1 % | +312.4 % | −40.7 % | +59.4 % | 98 | 42 | 12.0 % | 12.7 % | 3.69 | — | 84.0 | 14.9 | 6.9 | — | 0.78 | 38.4 | -8.6 % | 29.6 % | -8.6 % | -6.1 % | -3.3 % | 0.16 | 70.6 % | +82.8 % | 5 | 0.0 % | 0.0 % | 7.6 | 68.3 % | 12.9 % | 4.2 (5) |
| VSH Vishay Intertechnology Inc | 08/05 | +42 % | 60 6/25 | Stage 2 | B 60 | 7 of 9 | 5.1 $ | Semiconductors | Uses AI | — | Technology | 34.20 $ | +309.9 % | +277.5 % | +113.2 % | −13.8 % | -0.6 % | 98 | 3 | 10.5 % | 10.5 % | 1.78 | 3,216.8 | 48.3 | 1.6 | 2.1 | — | 1.35 | 18.8 | 2.4 % | 19.9 % | 0.1 % | 0.1 % | 0.9 % | 0.53 | 48.7 % | +4.5 % | 3 | 1.2 % | 4.0 % | 6.9 | 109.0 % | 12.5 % | 3.8 (4) | |
| UCTT Ultra Clean Holdings Inc | 07/27 | +70 % | 92 10/25 | Stage 2 | C 45 | 2 of 9 | 4.1 $ | Semiconductor Equipment & Materials | Uses AI | — | Technology | 83.30 $ | +340.7 % | +399.2 % | +269.9 % | −3.5 % | +39.7 % | 98 | 17 | 8.9 % | 8.7 % | 1.83 | — | 34.6 | 2.0 | 5.9 | — | 0.99 | 349.0 | 2.1 % | 15.6 % | -9.4 % | -22.5 % | 1.4 % | 1.52 | 33.9 % | -2.1 % | 5 | 0.0 % | 0.0 % | 6.3 | 102.9 % | 10.7 % | 4.8 (4) | |
| ORKA Oruka Therapeutics, Inc. | 08/10 | +78 % | 79 7/22 | Stage 2 | D 33 | 1 of 9 | 6.0 $ | Biotechnology | – | — | — | Healthcare | 96.50 $ | +175.2 % | +188.0 % | +610.2 % | −4.8 % | +53.5 % | 98 | 42 | 7.5 % | 6.8 % | — | — | 0.0 | — | 12.0 | — | — | 0.0 | 0.0 % | — | 0.0 % | -27.3 % | -18.9 % | 0.00 | 96.5 % | +1,105.3 % | 2 | 0.0 % | 0.0 % | 34.0 | 89.1 % | 22.3 % | 4.9 (8) |
| PENG Penguin Solutions, Inc. | 07/07 | +53 % | — | Stage 2 | B 69 | 7 of 9 | 0.0 $ | Information Technology Services | Sells AI | — | Technology | 52.60 $ | +242.3 % | +236.2 % | +123.3 % | −13.7 % | -24.9 % | 98 | 50 | 11.5 % | 11.1 % | 2.83 | 95.6 | 12.5 | — | 8.6 | — | — | 27.4 | 7.8 % | 28.3 % | 4.1 % | 9.6 % | 3.0 % | 0.94 | 34.2 % | +16.9 % | 4 | 0.0 % | 0.0 % | 6.7 | 117.0 % | 28.7 % | 1.1 (8) | |
| TNGX Tango Therapeutics Inc | 08/04 | +91 % | — | Stage 2 | D 39 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 27.20 $ | +220.4 % | +274.3 % | +350.0 % | −12.4 % | +45.4 % | 98 | 50 | 6.5 % | 9.4 % | 1.13 | — | 0.0 | — | — | — | — | -0.9 | -206.2 % | -126.8 % | -188.2 % | -38.4 % | -20.7 % | — | 89.8 % | +48.3 % | 3 | 0.0 % | 0.0 % | 11.7 | 113.9 % | 21.2 % | 1.0 (8) |
| ICHR Ichor Holdings Ltd | 08/03 | +53 % | 92 10/25 | Stage 2 | B 55 | 4 of 9 | 2.7 $ | Semiconductor Equipment & Materials | – | — | — | Technology | 75.30 $ | +400.3 % | +460.1 % | +280.3 % | −6.5 % | +22.6 % | 98 | 28 | 9.2 % | 8.9 % | 1.78 | — | 55.2 | 2.8 | — | 26,630.0 | 0.79 | 226.8 | 1.1 % | 12.0 % | -5.3 % | -7.4 % | -0.3 % | — | 68.7 % | +11.6 % | 2 | 0.0 % | 0.0 % | 7.5 | 95.3 % | 6.4 % | 4.4 (7) |
| VPG Vishay Precision Group Inc | 08/04 | +90 % | 62 6/25 | Stage 2 | C 48 | 4 of 9 | 1.3 $ | Scientific & Technical Instruments | – | — | — | Technology | 92.10 $ | +248.5 % | +260.0 % | +247.1 % | −9.7 % | +2.8 % | 98 | 3 | 8.4 % | 9.5 % | 1.43 | — | 102.0 | 4.0 | — | — | 5.11 | 42.8 | 0.9 % | 39.2 % | 1.8 % | 1.8 % | 1.4 % | — | 73.8 % | +0.2 % | 3 | 0.0 % | 0.0 % | 10.5 | 98.4 % | 11.0 % | 5.0 (2) |
| BAND Bandwidth Inc | 07/29 | +106 % | 87 9/25 | Stage 2 | C 50 | 7 of 9 | 1.3 $ | Software - Infrastructure | Sells AI | — | Technology | 39.10 $ | +241.3 % | +304.3 % | +181.4 % | −31.1 % | +72.0 % | 98 | 42 | 8.6 % | 8.7 % | 2.92 | — | 23.0 | 1.6 | 3.1 | 16.3 | — | 27.4 | -2.2 % | 37.2 % | 0.3 % | -1.4 % | -0.9 % | 1.04 | 41.2 % | +0.7 % | 3 | 0.0 % | 0.0 % | 3.6 | 80.1 % | 12.2 % | 3.3 (6) | |
| HYLN Hyliion Holdings Corp. | 08/11 | +90 % | — | Stage 2 | B 55 | 4 of 9 | 0.0 $ | Auto Parts | Uses AI | — | Consumer Cyclical | 3.60 $ | +231.5 % | +141.9 % | +137.3 % | −42.8 % | +44.0 % | 98 | 50 | 13.6 % | 15.8 % | 3.47 | — | 0.0 | — | — | — | — | -0.8 | -481.7 % | 6.3 % | 0.0 % | -25.2 % | -17.5 % | — | 95.3 % | +130.3 % | 6 | 0.0 % | 0.0 % | 21.4 | 25.2 % | 7.6 % | 2.0 (1) | |
| SLS Sellas Life Sciences Group Inc | 08/11 | +148 % | — | Stage 2 | C 53 | 3 of 9 | 0.0 $ | Biotechnology | Uses AI | — | Healthcare | 10.00 $ | +140.6 % | +444.0 % | +529.6 % | −4.8 % | -5.0 % | 98 | 50 | 12.4 % | 11.1 % | 2.43 | — | 0.0 | — | — | — | — | -1.7 | 0.0 % | — | 0.0 % | -43.6 % | -25.5 % | — | 94.1 % | -100.0 % | 1 | 0.0 % | 0.0 % | 16.0 | 27.6 % | 32.4 % | 1.0 (3) | |
| ALOT AstroNova Inc | — | +30 % | 95 11/25 | Stage 2 | C 51 | 9 of 9 | 0.2 $ | Computer Hardware | Neutral | — | Technology | 29.00 $ | +228.3 % | +249.6 % | +156.2 % | −0.8 % | -8.6 % | 98 | 81 | 8.8 % | 6.2 % | 0.86 | — | 14.0 | 1.5 | — | 22.6 | — | 38.6 | — | 33.8 % | -0.9 % | -1.8 % | 2.6 % | — | — | -0.5 % | — | 0.0 % | 0.0 % | 7.3 | 44.9 % | 0.2 % | — | |
| STRL Sterling Construction Company Inc | 08/03 | +532 % | 48 6/29 | Stage 2 | A 82 | 7 of 9 | 19.1 $ | Engineering & Construction | Uses AI | — | — | Industrials | 596.80 $ | +191.4 % | +159.2 % | +123.0 % | −12.3 % | +58.6 % | 97 | 88 | 7.1 % | 7.5 % | 1.83 | 48.7 | 31.6 | 6.6 | 14.0 | 43.5 | 1.02 | 30.8 | 17.2 % | 23.3 % | 12.0 % | 36.7 % | 12.9 % | 0.57 | 42.7 % | +17.7 % | 5 | 0.0 % | 0.0 % | 6.7 | 95.7 % | 4.8 % | 5.0 (3) |
| NVTS Navitas Semiconductor Corp | 08/03 | -3 % | 61 6/25 | Stage 2 | D 31 | 2 of 9 | 2.7 $ | Semiconductors | – | — | — | Technology | 10.90 $ | +199.7 % | +131.6 % | +48.2 % | −48.2 % | +29.1 % | 97 | 42 | 10.1 % | 12.8 % | 3.82 | — | 0.0 | 74.2 | 6.5 | — | — | -7.7 | -317.7 % | 38.1 % | 0.0 % | -35.2 % | -9.0 % | 0.02 | 87.3 % | -44.9 % | 3 | 0.0 % | 0.0 % | 7.5 | 46.3 % | 18.4 % | 4.0 (8) |
| ATEX Anterix Inc | 08/11 | +51 % | 89 9/24 | Stage 2 | A 78 | 7 of 9 | 1.8 $ | Telecom Services | Neutral | — | Communication Services | 93.00 $ | +266.4 % | +339.9 % | +318.8 % | −8.1 % | +15.8 % | 97 | 85 | 8.3 % | 8.2 % | 0.83 | 21.3 | 0.0 | 266.2 | 7.7 | 319.5 | — | -12.4 | — | 100.0 % | 1,394.2 % | 43.3 % | -6.5 % | 0.02 | — | +7.8 % | 6 | 0.0 % | 0.0 % | 3.5 | 91.8 % | 16.9 % | 4.7 (3) | |
| QUIK QuickLogic Corporation | 08/11 | +46 % | 87 9/25 | Stage 2 | D 41 | 7 of 9 | 0.2 $ | Semiconductors | – | — | — | Technology | 13.10 $ | +231.7 % | +196.4 % | +106.8 % | −24.3 % | +28.6 % | 97 | 42 | 8.5 % | 9.5 % | 1.18 | — | 103.1 | 15.9 | — | — | 1.50 | 210.1 | — | 20.7 % | -102.3 % | -49.2 % | -18.0 % | — | — | -31.5 % | — | 0.0 % | 0.0 % | -28.1 | 28.3 % | 4.7 % | — |
| RFIL RF Industries Ltd | — | +133 % | 85 10/29 | Stage 2 | B 62 | 7 of 9 | 0.1 $ | Electrical Equipment & Parts | Neutral | — | Industrials | 12.30 $ | +265.4 % | +254.2 % | +49.5 % | −6.1 % | -14.1 % | 97 | 61 | 12.2 % | 9.9 % | 1.28 | 96.8 | 9.9 | 1.6 | 3.6 | 103.1 | — | 44.0 | — | 34.6 % | 1.7 % | 3.9 % | 3.4 % | 0.65 | — | +24.3 % | — | 0.0 % | 0.0 % | 6.5 | 44.1 % | 1.3 % | — | |
| CVGI Commercial Vehicle Group Inc | 08/03 | -17 % | 74 9/31 | Stage 2 | C 48 | 7 of 9 | 0.2 $ | Auto Parts | – | — | — | Consumer Cyclical | 4.50 $ | +228.5 % | +212.2 % | +168.1 % | −19.4 % | +51.2 % | 96 | 70 | 7.6 % | 7.1 % | 1.43 | — | 13.5 | 0.2 | 1.2 | 8.3 | 0.27 | 12.7 | — | 11.7 % | -2.7 % | -12.3 % | 0.6 % | 0.78 | — | -10.3 % | — | 0.0 % | 0.0 % | 5.4 | 46.7 % | 1.7 % | — |
| MGNX MacroGenics Inc | 08/13 | -6 % | 94 9/22 | Stage 2 | D 38 | 5 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.70 $ | +191.3 % | +200.0 % | +136.5 % | −8.3 % | +44.8 % | 96 | 8 | 8.1 % | 7.0 % | 1.18 | — | 61.0 | 1.5 | — | — | 0.01 | 5.6 | — | -16.2 % | -44.8 % | -140.3 % | -18.0 % | — | — | +0.8 % | — | 0.0 % | 0.0 % | -15.0 | 70.3 % | 7.8 % | — |
| STRO Sutro Biopharma | 08/06 | -14 % | 89 8/22 | Stage 2 | D 31 | 6 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 24.20 $ | +152.3 % | +210.2 % | +200.1 % | −32.6 % | +97.3 % | 96 | 42 | 9.7 % | 10.4 % | 1.52 | — | 10.0 | 4.0 | 1.7 | — | — | 41.7 | — | -52.0 % | -154.2 % | -1,810.0 % | -19.3 % | -0.20 | — | +65.2 % | — | 0.0 % | 0.0 % | -9.7 | 86.8 % | 10.0 % | 3.7 (10) |
| SVCO Silvaco Group, Inc. Common Stock | 08/05 | — | 74 7/25 | Stage 2 | D 43 | 4 of 9 | 0.3 $ | Software - Application | Sells AI | — | — | Technology | 7.80 $ | +218.0 % | +185.7 % | +74.8 % | −15.5 % | +26.9 % | 96 | 42 | 9.8 % | 9.6 % | 0.39 | — | 416.7 | 3.9 | 3.4 | — | — | 194.4 | — | 80.5 % | -41.7 % | -34.7 % | -12.9 % | 0.03 | — | +5.7 % | — | 0.0 % | 0.0 % | 2.2 | 24.3 % | 9.5 % | — |
| ELVN Enliven Therapeutics Inc. | 08/12 | +44 % | 69 6/22 | Stage 2 | D 29 | 4 of 9 | 3.7 $ | Biotechnology | – | — | — | Healthcare | 54.80 $ | +215.6 % | +203.9 % | +191.4 % | −2.8 % | +22.1 % | 95 | 42 | 6.6 % | 6.9 % | 0.26 | — | 0.0 | — | 8.8 | — | — | -6.3 | 0.0 % | — | 0.0 % | -26.6 % | -18.9 % | 0.00 | 97.5 % | — | 2 | 0.0 % | 0.0 % | 47.0 | 89.7 % | 17.7 % | 4.9 (8) |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C 51 | 3 of 9 | 7.4 $ | Biotechnology | Uses AI | — | Healthcare | 7.20 $ | +269.7 % | +309.8 % | +191.5 % | −37.3 % | +77.1 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 52.7 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | 6 | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.6 % | 4.6 (5) | |
| ATOM Atomera Inc | 08/04 | +0 % | 35 4/25 | Stage 2 | D 43 | 7 of 9 | 0.2 $ | Semiconductor Equipment & Materials | – | — | — | Technology | 5.20 $ | +240.7 % | +238.2 % | +3.2 % | −40.9 % | +36.8 % | 94 | 42 | 9.6 % | 11.6 % | 2.05 | — | 0.0 | 2,010.0 | 5.0 | — | — | -8.7 | — | -520.8 % | 0.0 % | -65.9 % | -39.3 % | 0.03 | — | -51.9 % | — | 0.0 % | 0.0 % | 1.4 | 42.1 % | 14.9 % | — |
| SATL Satellogic V Inc | 08/11 | +64 % | 94 12/29 | Stage 2 | B 60 | 5 of 9 | 0.5 $ | Aerospace & Defense | – | — | — | Industrials | 3.60 $ | +197.3 % | +157.5 % | +9.2 % | −61.8 % | +213.3 % | 89 | 42 | 10.6 % | 11.7 % | 1.27 | — | 0.0 | 26.8 | 16.2 | — | — | 245.5 | — | 75.1 % | 0.0 % | -127.6 % | -14.0 % | -5.86 | — | +37.6 % | 4 | 0.0 % | 0.0 % | -6.2 | 55.4 % | 17.1 % | — |
| HURA TuHURA Biosciences Inc | 08/13 | -33 % | 82 7/22 | Stage 3 | E 19 | 3 of 9 | 0.1 $ | Biotechnology | Neutral | — | Healthcare | 2.20 $ | +248.7 % | +177.9 % | -12.5 % | −33.6 % | +210.4 % | 86 | 42 | 10.2 % | 9.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -187.2 % | -81.9 % | — | — | — | — | 0.0 % | 0.0 % | -16.0 | 15.0 % | 15.8 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Kullamägi's biggest-gainers screen over 6 months — exactly per his original filters: 6-month Absolute Strength rating (AS) > 97, the strongest roughly 3% over the half-year; plus ADR ≥ 3.5% and average dollar volume over the last 50 days > $1.5M. The long-term leaders — where the cleanest continuation bases form. AS = our RS rating (percentile 1–99).
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 36 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- CANSLIM Type RS
- Character Change (CC)
- Chris Perruna: Daily New Highs
- Chris Perruna: Within 15% of Highs
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Cross Fire
- Mike Webster: Down Days Tell Screen
- Mike Webster: Power Trend Leader
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: 52 Week Highs
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Power Trend
- Qullamaggie: Top Gainers 1M
- Qullamaggie: Top Gainers 3M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: 1 Week Top Performers
- Richard Moglen: Gaps and Strong Moves
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 1
- Stan Weinstein: Stage 2
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.